代谢功能障碍相关脂肪性肝病与非酒精性脂肪性肝病：对有更高肾脏损伤风险的肥胖儿童的更好定义。 - Suppr | 超能文献

相似文献

1

MASLD vs. NAFLD: A better definition for children with obesity at higher risk of kidney damage.代谢功能障碍相关脂肪性肝病与非酒精性脂肪性肝病：对有更高肾脏损伤风险的肥胖儿童的更好定义。

J Hepatol. 2024 Feb;80(2):e87-e89. doi: 10.1016/j.jhep.2023.10.021. Epub 2023 Oct 27.

2

Pediatric MASLD: current understanding and practical approach.小儿 MASLD：当前认识与实用方法。

Eur J Pediatr. 2024 Nov 19;184(1):29. doi: 10.1007/s00431-024-05848-1.

3

Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease.胰岛素抵抗和中心性肥胖决定肝脂肪变性，并解释脂肪性肝病患者的心血管风险。

Front Endocrinol (Lausanne). 2023 Sep 29;14:1244405. doi: 10.3389/fendo.2023.1244405. eCollection 2023.

4

The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.不同胰岛素抵抗指数在评估超重/肥胖儿童非酒精性脂肪性肝病中的价值。

Diabetes Metab Syndr. 2015 Apr-Jun;9(2):114-9. doi: 10.1016/j.dsx.2013.10.008. Epub 2013 Nov 14.

5

Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity.肥胖儿童中非酒精性脂肪性肝病（NAFLD）的预测因素

J Pediatr Endocrinol Metab. 2020 Feb 25;33(2):247-253. doi: 10.1515/jpem-2019-0403.

6

Alanine aminotransferase cutoffs for the pediatric fatty liver disease: Major impact of the reference population.丙氨酸氨基转移酶界值用于儿科脂肪性肝病：参考人群的重要影响。

J Pediatr Gastroenterol Nutr. 2024 Mar;78(3):488-496. doi: 10.1002/jpn3.12040. Epub 2023 Dec 10.

7

[Analysis of non-alcoholic fatty liver disease differences from metabolic dysfunction-associated fatty liver disease based on clinical features].基于临床特征分析非酒精性脂肪性肝病与代谢功能障碍相关脂肪性肝病的差异

Zhonghua Gan Zang Bing Za Zhi. 2024 Apr 20;32(4):346-353. doi: 10.3760/cma.j.cn501113-20231022-00153.

8

Pediatric Non-alcoholic Fatty Liver Disease.小儿非酒精性脂肪性肝病

Curr Gastroenterol Rep. 2016 May;18(5):24. doi: 10.1007/s11894-016-0498-9.

9

Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement.定义儿科代谢（功能）相关脂肪性肝病：国际专家共识声明。

Lancet Gastroenterol Hepatol. 2021 Oct;6(10):864-873. doi: 10.1016/S2468-1253(21)00183-7. Epub 2021 Aug 6.

10

Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis.当前非酒精性脂肪性肝病管理指南：系统评价与比较分析。

World J Gastroenterol. 2018 Aug 14;24(30):3361-3373. doi: 10.3748/wjg.v24.i30.3361.

引用本文的文献

1

Metabolic dysfunction-associated steatotic liver disease is associated with the risk of severe liver fibrosis in pediatric population.代谢功能障碍相关脂肪性肝病与儿童人群严重肝纤维化风险相关。

Gastroenterol Rep (Oxf). 2025 Jun 16;13:goaf056. doi: 10.1093/gastro/goaf056. eCollection 2025.

2

Liver-Kidney Crosstalk in Major Pediatric Diseases: Unraveling the Complexities and Clinical Challenges.儿童重大疾病中的肝肾相互作用：解析复杂性与临床挑战

J Clin Med. 2025 Jun 2;14(11):3911. doi: 10.3390/jcm14113911.

3

Kidney Damage in Pediatric Obesity: Insights from an Emerging Perspective.